Anti idiotype Antibody Development Services
Looking for reliable, application matched anti idiotype antibodies for PK or immunogenicity studies?
Anti‑idiotype antibodies are essential reagents in pharmacokinetic (PK) assays, immunogenicity (ADA) assessments, and mechanistic studies involving therapeutic antibodies. They enable specific detection, quantification, and functional characterisation of monoclonal drugs in complex matrices.
At CER Groupe, we design and generate custom anti‑idiotype antibodies precisely adapted to your therapeutic target, assay format and regulatory expectations.
Every project is fully tailored, ISO9001‑driven, and delivered under a 100% fee‑for‑service model, meaning you retain full IP ownership on all generated anti‑ID antibodies and materials.
Our Anti‑idiotype Antibody Capabilities
Share your therapeutic antibody and the intended assay format — we design the optimal anti‑ID development plan together.
1. Different anti‑ID formats
We develop the exact type of anti‑idiotype you need:
- Blocking anti‑IDs (bind to the paratope and compete with antigen)
- Non‑blocking anti‑IDs (bind outside the paratope, ideal for sandwich assays)
- Complex-specific anti-IDs (bind only the antigen-antibody complex)
2. Polyclonal and monoclonal anti‑ID workflows
Depending on your assay constraints, timelines, and regulatory requirements, we help you select the ideal approach:
- Rabbit polyclonal anti‑IDs (broad coverage, fast TAT)
- Mouse or rat monoclonal anti‑IDs (high specificity, consistent supply)
3. Designed specifically for PK and ADA applications
Our anti‑IDs are built to support:
- Pharmacokinetic (PK) quantification
- Anti‑drug antibody (ADA) assays
- Immunogenicity monitoring
- Ligand‑binding assays
- Neutralisation assays
- Method development & qualification (non-GLP or GLP)
4. End‑to‑end support with a custom, transparent approach
- Guidance on antigen form (drug, Fab, scFv, …)
- Immunisation and screening strategy adapted to your assay
- Optional purification (Protein A/G, antigen‑affinity), conjugation , and format adaptation
- Application‑oriented validation (binding, specificity, cross‑reactivity)
- Easy progression toward engineering or biomanufacturing (dedicated pages)
5. Quality, ethics, and full IP retention
- ISO9001-certified processes
- Animals managed in a 3R‑compliant facility
- Full traceability and study documentation
- No IP claim — you own the antibody sequences, materials, and data